Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 02/29/24
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment | NCT06677255 | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | user2@example.com | None | 2025-01-31 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) | NCT06230822 | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | user2@example.com | None | 2024-02-29 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |